These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2273661)

  • 1. [CA 19-9 in patients with benign pulmonary diseases].
    Takayama S; Kataoka N; Usui Y; Inase N; Natori Y; Nakayama M; Miura H; Kimula Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Oct; 28(10):1326-31. PubMed ID: 2273661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis].
    Kondo A; Oketani N; Maruyama M; Taguchi Y; Yamaguchi Y; Miyao H; Mashima I; Oono M; Wada K; Tsuchiya T; Takahashi H; Abe S
    Kekkaku; 1998 Oct; 73(10):585-90. PubMed ID: 9844346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of sialylated carbohydrate antigen in patients with benign bronchopulmonary disease].
    Yokoyama T; Ikedou Y; Kido F; Tanoue S; Tashiro K; Ninomiya H; Rikimaru T; Kajiki A; Takamoto M; Ishibashi T; Oizumi K
    Nihon Kokyuki Gakkai Zasshi; 1998 Oct; 36(10):851-6. PubMed ID: 9893426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR; Koda JE; Gaur PK
    Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer.
    Spila A; Ferroni P; Cosimelli M; D'Alessandro R; Carone MD; Aloe S; Tedesco M; Mancini R; Casale V; Carlini S; Casciani CU; Roselli M; Guadagni F
    Anticancer Res; 1999; 19(2B):1363-8. PubMed ID: 10365107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of serum CA 19-9 determination in digestive tract cancer].
    Chen SB
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):58-60. PubMed ID: 2364873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients.
    Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
    Cancer Res; 1988 Mar; 48(6):1435-8. PubMed ID: 3162196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
    Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
    Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of Nickel Subsulfide (CAS No. 12035-72-2) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 453():1-365. PubMed ID: 12594522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An autopsied case of idiopathic interstitial pneumonia, showing a remarkably elevated serum level of CA 19-9].
    Okino T; Yamadori I; Ogino T; Miki H; Hirakawa E; Morikawa T; Kobayashi S; Ohmori M; Bungo M; Yamaji Y
    Gan No Rinsho; 1989 Jan; 35(1):69-73. PubMed ID: 2921812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic significance of carbohydrate antigen CA 19-9 in serum and pancreatic juice in pancreatic carcinoma.
    Chen YF; Mai CR; Tie ZJ; Feng ZT; Zhang J; Lu XH; Lu GJ; Xue YH; Pan GZ
    Chin Med J (Engl); 1989 May; 102(5):333-7. PubMed ID: 2509154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum levels and clinical evaluation of CA 19-9 in various diseases].
    Toyama K; Noto M; Sakaguchi T; Adachi K; Mitomi H; Okada N; Ootaka H; Nakazawa H; Hara E
    Gan No Rinsho; 1985 Mar; 31(3):293-8. PubMed ID: 2582158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CA-125 in non-ovarian benign and malignant pathology: study on 380 patients].
    Marechal F; Berthiot G; Kritly T; Legrand MG; Deltour G; Cattan A
    Bull Cancer; 1989; 76(7):697-706. PubMed ID: 2819261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen (CEA) and gastrointestinal cancer associated antigen CA 19-9 in bronchioloalveolar carcinomas and pulmonary adenocarcinomas.
    Heikkilä L; Suomalainen RJ; Lindgren J; Jalanko H; Harjula A; Mattila S
    Ann Chir Gynaecol; 1986; 75(5):260-5. PubMed ID: 3030184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of the tumor marker CA 72-4 in gastric carcinoma].
    Martín-Pérez E; Fernández-Arjona M; Baza B; Villanueva C; Larrañaga E; Serrano PA; Clerigué A
    Rev Esp Enferm Dig; 1993 Feb; 83(2):92-6. PubMed ID: 8471361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.
    Spila A; Ferroni P; Cosimelli M; D'Alessandro R; Abbolito MR; Mariotti S; Aloe S; Carone MD; Graziano F; Tedesco M; Martini F; Mancini R; Stigliano V; Roselli M; Guadagni F
    Anticancer Res; 2001; 21(2B):1263-70. PubMed ID: 11396197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increased levels of Ca 19-9, Ca 50 and Ca 125 in patients with benign diseases of the biliary tract and the pancreas].
    Piantino P; Fusaro A; Randone A; Cerchier A; Daziano E
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):97-102. PubMed ID: 2092159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The diagnostic significance of carbohydrate antigen 19-9 in pancreatic carcinomas].
    Chen YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Jun; 11(3):229-31. PubMed ID: 2529993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma.
    Guadagni F; Roselli M; Cosimelli M; Ferroni P; Spila A; Casaldi V; Cavaliere F; Carlini M; Garofalo A; Rinaldi G
    Anticancer Res; 1993; 13(6B):2409-13. PubMed ID: 8135475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the clinical usefulness of CA 19-9 and CA 50 in the diagnosis and monitoring of gastrointestinal cancers.
    Kokociñska D; Jarzab B; Król R; Ziaja K; Szejbak K; Kuśmierski S
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):283-7. PubMed ID: 9216823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.